ACTIVE SUBSTANCE / INN

UBLITUXIMAB

Brand name(s): Briumvi

EMA LISTED

AUTHORISED

Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis

ACTIVE SUBSTANCE

Ublituximab

REGULATORS

EMA

SPONSORS / MAH

Neuraxpharm Pharmaceuticals S.L.

TOTAL APPLICATIONS

EMA AUTHORISATIONS

PRODUCT NAME	HOLDER	STATUS	DATE	INDICATION
Briumvi	Neuraxpharm Pharmaceuticals S.L.	Authorised	31/05/2023	Multiple Sclerosis, Relapsing-Remitting;Multiple Sclerosis

FULL INTELLIGENCE ON UBLITUXIMAB